DeMarzo Arthur P
Dermed Diagnostics Inc, 2-S 558 White Birch Lane, Wheaton, Illinois, 60189, USA.
High Blood Press Cardiovasc Prev. 2018 Jun;25(2):219-221. doi: 10.1007/s40292-018-0255-2. Epub 2018 Feb 22.
New guidelines on hypertension eliminated the classification of prehypertension and divided those blood pressure (BP) levels into elevated BP and stage 1 hypertension. For elevated BP, this study showed that cardiovascular (CV) abnormalities were prevalent in adults over 40 years of age with at least 2 CV risk factors. Detecting abnormalities of the CV system moves a patient from being at high risk to having earlystage cardiovascular disease (CVD) and supports a decision to treat. By redefining stage 1 and lowering the target BP, the new guidelines have set an ambitious goal for early intervention to prevent progression of CVD. Proper drug selection and titration are critical. Hypertensive patients have diverse CV abnormalities that can be quantified by impedance cardiography. By stratifying patients with ventricular, vascular, and hemodynamic abnormalities, treatment can be customized based on the abnormal underlying mechanisms to rapidly control BP and prevent progression of CVD.
高血压新指南取消了高血压前期的分类，并将这些血压（BP）水平分为血压升高和1期高血压。对于血压升高，本研究表明，在40岁以上且至少有2种心血管（CV）危险因素的成年人中，心血管异常普遍存在。检测心血管系统异常可使患者从高危状态转变为患有早期心血管疾病（CVD），并支持治疗决策。通过重新定义1期高血压并降低血压目标，新指南为早期干预以预防CVD进展设定了一个宏伟目标。正确的药物选择和滴定至关重要。高血压患者存在多种心血管异常，可通过阻抗心动图进行量化。通过对存在心室、血管和血流动力学异常的患者进行分层，可以根据潜在的异常机制定制治疗方案，以快速控制血压并预防CVD进展。
